Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice

Combination Paclitaxel and Inhibitor of Nuclear Factor κB Activation Improves Therapeutic Outcome for Model Mice With Peritoneal Dissemination of Pancreatic Cancer

(2011) Yuki Fujiwara et al.   PANCREAS

Anti-tumor effect by inhibition of NF-κB activation using nafamostat mesilate for pancreatic cancer in a mouse model

(2010) Furukawa   ONCOLOGY REPORTS

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

(2009) H. Ishigami et al.   ANNALS OF ONCOLOGY

A protocol for immunoaffinity separation of the accumulated ubiquitin–protein conjugates solubilized with sodium dodecyl sulfate

(2008) Yohta Shimada et al.   ANALYTICAL BIOCHEMISTRY

A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer

(2008) T. Uwagawa et al.   ANNALS OF ONCOLOGY

Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer

(2008) Masashi Inoue et al.   INTERNATIONAL JOURNAL OF CANCER

Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma

(2008) Sheng Ye et al.   WORLD JOURNAL OF GASTROENTEROLOGY